An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson's disease

Clinical Neurophysiology

Volumn 118, Issue 10, 2007, Pages 2189-2194

  Epstein, Charles M ^a   Evatt, Marian L ^a   Funk, Agnes ^a   Girard Siqueira, Lhys ^a   Lupei, Nichole ^a   Slaughter, Larisa ^a   Athar, Saima ^a   Green, Joanne ^a   McDonald, William ^a   DeLong, Mahlon R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Parkinson disease; Transcranial magnetic stimulation

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; DATA INTERPRETATION, STATISTICAL; DEPRESSIVE DISORDER; DRUG RESISTANCE; FEASIBILITY STUDIES; FEMALE; HUMANS; INPATIENTS; MALE; MIDDLE AGED; MOVEMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 34548595458     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2007.07.010     Document Type: Article

References (42)

1. Avery D., Holtzheimer P.E., Fawaz W., Russo J., Neumaier J., Dunner D., et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry 59 (2006) 187-194
2. Beck A.T. The diagnosis and management of depression (1973), University of Pennsylvania, Philadelphia
3. Benito-Leon J., Bermejo-Pareja F., Rodriguez J., Molina J.-A., Gabriel R., and Morales J.-M. Prevalence of PD and other types of Parkinsonism in three elderly populations of central Spain. Mov Disord 18 (2003) 267-274
4. Berman R., Narasimhan M., Sanacora G., Miano A.P., Hoffman R.E., Hu X.S., et al. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biol Psychiatry 47 (2000) 332-337
5. Boggio P., Fregni F., Bermpohl F., Mansur C., Rosa M., Rumi D.O., et al. Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression. Mov Disord 20 (2005) 1178-1184
6. Epstein C., and Davey K. Iron-core coils for transcranial magnetic stimulation. J Clin Neurophysiol 19 (2002) 376-381
7. Epstein C., Figiel G.S., MacDonald W.M., Amazon-Leece J., and Figiel L. Rapid-rate transcranial magnetic stimulation in young and middle-aged refractory depressed patients. Psychiatr Ann 28 (1998) 36-39
8. Fahn S., and Elton R. Members of the UPDRS Development Committee. The UPDRS. In: Fahn S., Marsden C., Calne D., and Goldstein M. (Eds). Recent Developments in Parkinson's Disease vol. 2 (1987), Macmillan Health Care Information, Florham Park, NJ 153-163 293-304
9. First M, Spitzer R, Gibbon M, Williams J. Structured clinical interview for DSM-IV axis I disorders, patient edition, 1995.
10. Floel A., Poeppel D., Buffalo E., Braun A., Wu C., Seo H.J., et al. Prefrontal cortex asymmetry for memory encoding of words and abstract shapes. Cereb Cortex (2004) 404-409
11. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12 (1975) 189-198
12. Fregni F., Santos C., Myczkowski M.L., Rigolino R., Gallucci-Neto J., Barbosa E.R., et al. Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 75 (2004) 1171-1174
13. de la Fuente-Fernandez R., Ruth T., Sossi V., Schulzer M., Calne D., and Stoessl A. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293 (2001) 1164-1166
14. Gelb D., Oliver E., and Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 56 (1999) 33-39
15. George M.S., Wassermann E.M., Kimbrell T.A., Little J.T., Williams W.E., Danielson A.L., et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry 154 (1997) 1752-1756
16. George M.S., Wassermann E.M., Williams W.A., Callahan A., Ketter T.A., Basser P.J., et al. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 6 (1995) 1853-1856
17. Goetz C., Leurgans S., Raman R., and Stebbins G. Objective changes in motor function during placebo treatment in PD. Neurology 54 (2000) 710-714
18. Guy W. Assessment Manual for Psychopharmacology. Rockville: US Department of Health Education and Welfare, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration 76-338, NIHM; 1976. p. 218-22.
19. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychiatry 32 (1959) 50-55
20. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychology 6 (1967) 278-296
21. Holtzheimer P., Russo J., and Avery D. A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol Bull (2003) 37
22. Ikeguchi M., Tougea T., Nishiyama Y., Takeuchi H., Kuriyama S., and Ohkawa M. Effects of successive repetitive transcranial magnetic stimulation on motor performances and brain perfusion in idiopathic Parkinson's disease. J Neurol Sci 209 (2003) 41-46
23. Isenberg K., Downs D., Pierce K., Svarakic D., Garcia K., Jarvis M., et al. Low frequency rTMS stimulation of the right frontal cortex is as effective as high frequency rTMS stimulation of the left frontal cortex for antidepressant-free, treatment-resistant depressed patients. Ann Clin Psychiatry 17 (2005) 153-159
24. Jeanneau A. Electroconvulsive therapy in the treatment of Parkinson disease. Encephale 19 (1993) 573-578
25. Keck M.E., Welt T., Müller M.B., Erhardt A., Ohl F., Toschi N., Holsboer F., and Sillaber I. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology 43 (2002) 101-109
26. Grunhaus L., Schreiber S., Dolberg O.T., Polak D., and Dannon P.N. A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression. Biol Psychiatry 53 (2003) 324-331
27. Lefaucheur J.-P., Drouota X., Raison F.V., Menard-Lefaucheur I., P P.C., and Nguyen J.-P. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease. Clin Neurophysiol 115 (2004) 2530-2541
28. Lomarev M., Kanchana S., Bara-Jimenez W., Iyer M., Wassermann E., and Hallett M. Placebo-controlled study of rTMS for the treatment of Parkinson's disease. Mov Disord 21 (2005) 325-331
29. Mally J., Farkas R., Tothfalusi L., and Stone T. Long-term follow-up study with repetitive transcranial magnetic stimulation (rTMS) in Parkinson's disease. Brain Res Bull 64 (2004) 259-263
30. Mattis S. Dementia rating scale (1988), Psychological Assessment Resources, Odessa, Florida
31. Okabe S., Ugawa Y., and Kanazawa I. 0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's disease. Mov Disord 18 (2003) 382-388
32. Olmo M., Bello O., and Cudiero J. Transcranial magnetic stimulation over dorsolateral prefrontal cortex in Parkinson's disease. Clin Neurophysiol 118 (2007) 131-139
33. Overall J., and Gorham D. The brief psychiatric rating scale. Psychol Rep 10 (1962) 799-812
34. Peto V., Jenkinson C., and Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 245 Suppl.1 (1998) S10-S14
35. Pridmore S., Fernandes Filho J.A., Nahas Z., Liberatos C., and George M.S. Motor threshold in transcranial magnetic stimulation: a comparison of a neurophysiological method and a visualization of movement method. J ECT 14 (1998) 25-27
36. Pridmore S., Yeo P.T., and Pasha M.I. Electroconvulsive therapy for the physical signs of Parkinson's disease without depressive disorder. J Neurol Neurosurg Psychiatry 58 (1995) 641-642
37. Randolph C. Repeatable battery for the assessment of neuropsychological status (manual) (1995), Psychological Corporation, San Antonio
38. Rossini P.M., Barker A.T., Berardelli A., Caramia M.D., Caruso G., Cracco R.Q., et al. Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91 (1994) 79-92
39. Schretlen D. Brief test of attention (1989), Psychological Assessment Resources, Inc., Lutz, Florida
40. Tandberg E., Larsen J., Aarsland D., and Cummings J. The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol 53 (1996) 175-179
41. Ward C., Stern G.M., Pratt R.T., and McKenna P. Electroconvulsive therapy in Parkinsonian patients with the "on-off" syndrome. J Neural Transmission 49 (1980) 133-135
42. Wengel S.P., Burke W.J., Pfeiffer R.F., Roccaforte W.H., and Paige S.R. Maintenance electroconvulsive therapy for intractable Parkinson's disease. Am J Geriatr Psychiatry 6 (1998) 263-269